Anti-MDA5 antibody-positive rapidly progressive interstitial pneumonia without cutaneous manifestations

Sato, 2016, Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies, PLoS One, 11, 10.1371/journal.pone.0154285 Nagata, 2011, Four cases of interstitial pneumonia associated with amyopathic dermatomyositis characterized by the anti-CADM-140 antibody, Ann. Jpn. Respir. Soc., 49, 30 Nakashima, 2013, Anti-MDA5(melanoma differentiation-associated gene 5) antibody and dermatomyositis with rapidly progressive interstitial pneumonia, Jpn. J. Clin. Immunol., 36, 71, 10.2177/jsci.36.71 Sato, 2009, RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease, Arthritis Rheum., 60, 2193, 10.1002/art.24621 Fiorentino, 2011, The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study, J. Am. Acad. Dermatol., 65, 25, 10.1016/j.jaad.2010.09.016 Muro, 2016, Cutaneous manifestations in dermatomyositis: key clinical and serological features-a comprehensive review, Clin. Rev. Allergy Immunol., 51, 293, 10.1007/s12016-015-8496-5 Juan, 2018, Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review, Rheumatol. Int., 2 Tamai, 2014, Early pulmonary involvement of anti-CADM-140 autoantibody-positive rapidly progressive interstitial lung disease preceding typical cutaneous symptoms, Intern. Med., 53, 2515, 10.2169/internalmedicine.53.2769 Ortiz, 2017, Anti-MDA5-positive dermatomyositis : an emerging entity with a variable clinical presentation, Scand. J. Rheumatol., 10, 509, 10.1080/03009742.2017.1340512 Nishina, 2018, Influence of season and residential environment on development of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis with interstitial lung disease, JADD, 78, 776 Yoneyama, 2005, Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity, J. Immunol., 175, 2851, 10.4049/jimmunol.175.5.2851 Yoneyama, 2004, The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses, Nat. Immunol., 5, 730, 10.1038/ni1087 Kato, 2005, Cell type-specific involvement of RIG-I in antiviral response, Immunity, 23, 19, 10.1016/j.immuni.2005.04.010 Kato, 2006, Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses, Nature, 441, 101, 10.1038/nature04734 Trinchieri, 2010, Type I interferon: friend or foe?, J. Exp. Med., 207, 2053, 10.1084/jem.20101664 Horai, 2015, Serum interferon-α is a useful biomarker in patients with anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis, Mod. Rheumatol., 25, 85, 10.3109/14397595.2014.900843 Gono, 2014, Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease, Rheumatology, 53, 2196, 10.1093/rheumatology/keu258 Nakashima, 2010, The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody, Rheumatology (Oxford), 49, 433, 10.1093/rheumatology/kep375 Sato, 2014, A case of dermatomyositis with anti-CADM-140 antibody and alveolar hemorrhage, Clin. Neurol., 54, 408